Rep. Langworthy Continues Push for Dietary Supplement Regulatory Uniformity Act

Why It Matters

A single, science‑based federal standard lowers compliance costs, protects consumer confidence, and sustains innovation in the fast‑growing supplement market.

Key Takeaways

• H.R. 7366 blocks divergent state supplement regulations.
• Exemptions allowed only if stricter and non‑conflicting.
• NPA backs bill to restore regulatory clarity.
• Patchwork rules increase costs and limit product choices.
• Congressional hearing highlighted need for national uniformity.

Pulse Analysis

Since the 1994 Dietary Supplement Health and Education Act, the FDA has been the sole regulator of dietary supplements, providing a consistent safety and labeling framework. In recent years, states such as New York and California have introduced their own age limits and ingredient bans, creating a fragmented regulatory landscape that confuses manufacturers and consumers alike. This state‑level activism reflects broader political pressures but threatens the uniformity that has underpinned industry growth for three decades.

H.R. 7366 seeks to codify federal primacy by amending the FD&C Act, permitting state rules only when they are stricter yet do not conflict with federal standards. The bill’s exemption clause aims to balance local health concerns with national consistency. Industry groups, led by the Natural Products Association, have rallied behind the legislation, emphasizing that a unified rulebook safeguards public health while fostering innovation. The recent House hearing, titled "Healthier America," highlighted bipartisan recognition of the costs and market disruption caused by divergent state mandates.

If enacted, the Uniformity Act would streamline compliance for manufacturers, reduce duplicate testing, and lower product pricing by eliminating the need for state‑specific reformulations. Retailers would benefit from a predictable inventory landscape, and consumers would enjoy consistent product availability across state lines. Moreover, the bill could set a precedent for other sectors facing similar state‑federal tensions, reinforcing the principle that science‑based federal oversight remains the most efficient path to market confidence and economic growth.